• Posted: April 17, 2019 MMRF Immunotherapy Initiative: Chimeric Antigen Receptor (CAR) T-Cell Therapy

    READ MORE
  • Posted: March 21, 2019 MMRF Answer Fund: How CoMMpass data is helping define high-risk disease

    READ MORE
  • Posted: February 22, 2019 Precision Medicine

    READ MORE
  • Posted: February 12, 2019 MyDRUG

    READ MORE
  • Posted: January 29, 2019 Promising Results from Our MMRC CarPan Trial

    READ MORE
  • Posted: December 4, 2018 ASH 2018 Day 3 - Therapy, excluding Transplantation: Antibodies and Targeted...

    READ MORE
  • Posted: December 4, 2018 ASH 2018 Day 3 - Immunotherapy

    READ MORE
  • Posted: December 4, 2018 ASH 2018 Day 3 - Oral CoMMpass ONLY

    READ MORE
  • Posted: December 4, 2018 ASH 2018 - Day 3: Novel Proteasome Inhibitors Update

    READ MORE
  • Posted: December 4, 2018 ASH 2018 - Day 3: Novel Treatment Combinations

    READ MORE

Page 1/18